Haibo Liang

Wenzhou, 325000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Time-ordered crosslinked hydrogel for full-cycle therapy of chronic wounds.

Time-ordered crosslinked hydrogel for full-cycle therapy of chronic wounds.

Journal: Biomaterials advances

Published: January 04, 2026

An engineered triple-network alginate/gelatin hydrogel mediates osteochondral regeneration through temporal regulation of the PI3K-AKT pathway.

An engineered triple-network alginate/gelatin hydrogel mediates osteochondral regeneration through temporal regulation of the PI3K-AKT pathway.

Journal: International journal of biological macromolecules

Published: November 13, 2025

Synergistic microenvironment therapy: a dual-function nanogel of supramolecular collagen ll-mimetic matrix and antioxidant MXene for attenuating intervertebral disc degeneration.

Synergistic microenvironment therapy: a dual-function nanogel of supramolecular collagen ll-mimetic matrix and antioxidant MXene for attenuating intervertebral disc degeneration.

Journal: Journal of nanobiotechnology

Published: October 29, 2025

Eugenol attenuates intervertebral disc degeneration by inhibiting nucleus pulposus cell ferroptosis via the Nrf2/GPX4 pathway.

Eugenol attenuates intervertebral disc degeneration by inhibiting nucleus pulposus cell ferroptosis via the Nrf2/GPX4 pathway.

Journal: Free radical biology & medicine

Published: September 28, 2025

UCHL1 alleviates nucleus pulposus cell senescence by promoting chaperone-mediated autophagy antagonizing autophagy-dependent ferroptosis through deubiquitination of HSPA8.

UCHL1 alleviates nucleus pulposus cell senescence by promoting chaperone-mediated autophagy antagonizing autophagy-dependent ferroptosis through deubiquitination of HSPA8.

Journal: Autophagy

Published: September 03, 2025

Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis.

Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis.

Journal: Bioactive materials

Published: September 02, 2025

A CREB5-NR4A1 checkpoint protects against disc degeneration by controlling ferroptosis.

A CREB5-NR4A1 checkpoint protects against disc degeneration by controlling ferroptosis.

Journal: Osteoarthritis and cartilage

Published: August 08, 2025

Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss.

Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss.

Journal: International immunopharmacology

Published: July 01, 2025

Idebenone attenuates RANKL-induced osteoclastogenesis and improves bone mass in ovariectomized mice.

Idebenone attenuates RANKL-induced osteoclastogenesis and improves bone mass in ovariectomized mice.

Journal: Free radical biology & medicine

Published: May 14, 2025

Crebanine protects against ovariectomy-induced bone loss by targeting Sirt1 to interfere with NF-κB acetylation and ROS activity.

Crebanine protects against ovariectomy-induced bone loss by targeting Sirt1 to interfere with NF-κB acetylation and ROS activity.

Journal: Journal of pharmaceutical analysis

Published: March 09, 2025

PTPN22 as a therapeutic target in intervertebral disc degeneration: Modulating mitophagy and pyroptosis through the PI3K/AKT/mTOR axis.

PTPN22 as a therapeutic target in intervertebral disc degeneration: Modulating mitophagy and pyroptosis through the PI3K/AKT/mTOR axis.

Journal: Journal of advanced research

Published: January 25, 2025

Catharanthine tartrate ameliorates osteoclastogenesis by destabilizing HIF-1α.

Catharanthine tartrate ameliorates osteoclastogenesis by destabilizing HIF-1α.

Journal: Cellular signalling

Published: January 03, 2025

Showing 1-12 of 20

Last Updated: 09/26/2026